Velan Capital Investment Management’s RAPT Therapeutics RAPT Stock Holding History

Velan Capital Investment Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-108,000	Closed	-$3.66M	–	53
2025 Q4	$3.66M	Buy	108,000 +28,023	+35%	+$870K	2.12%	15
2025 Q3	$2.06M	Buy	+79,977	New	+$1.05M	1.94%	16
2022 Q2	–	Sell	-13,750	Closed	-$2.42M	–	25
2022 Q1	$2.42M	Hold	13,750	–	–	2.24%	14
2021 Q4	$4.04M	Buy	+13,750	New	+$3.68M	3.14%	10

Velan Capital Investment Management's RAPT Position: Q1 2026 in Review

Velan Capital Investment Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 108,000 shares — an estimated $3.66M sold.

Velan Capital Investment Management first reported a position in RAPT in Q4 2021 and held it in 4 quarters. The position peaked at $4.04M in Q4 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Velan Capital Investment Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Velan Capital Investment Management sold 108,000 RAPT Therapeutics shares in Q1 2026, an estimated $3.66M.
Velan Capital Investment Management first reported a position in RAPT Therapeutics in Q4 2021 and held it in 4 quarters.
Velan Capital Investment Management's RAPT Therapeutics position peaked at $4.04M in Q4 2021.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.